Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor

Steroids

Volumn 61, Issue 4, 1996, Pages 257-262

  Göttlicher, Martin ^a   Heck, Stefanie ^a   Doucas, Vassilis ^b   Wade, Erik ^a   Kullmann, Michael ^a   Cato, Andrew C B ^a   Evans, Ronald M ^b   Herrlich, Peter ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

AP I; Cross talk; Fos; GR mutants; Interaction screen; Repression; Two hybrid system; Ubiquitin

Indexed keywords

MAMMALIA;

GLUCOCORTICOID RECEPTOR; UBIQUITIN CONJUGATING ENZYME;

CONFERENCE PAPER; CONFORMATIONAL TRANSITION; HORMONE RESPONSIVE ELEMENT; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; FUNGAL PROTEINS; GENES, LETHAL; HUMANS; HYBRID CELLS; LIGASES; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, GLUCOCORTICOID; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTOR AP-1; UBIQUITIN-CONJUGATING ENZYMES;

EID: 0030002948     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-128X(96)00032-3     Document Type: Article

References (40)

1. Pratt WB (1993). The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J Biol Chem 268:1455-1458.
2. Beato M, Herrlich P, Schütz G (1995). Steroid hormone receptors: Many actors in search of a plot. Cell 83:851-857.
3. Mangelsdorf DJ, Thumel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995). The nuclear receptor superfamily: the second decade. Cell 83:835-839.
4. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M (1994). Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458.
5. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751.
6. Le Douarin B, Zechel C, Gamier JM, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R (1995). The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033.
7. Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M (1995). Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290.
8. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr (1995). Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
9. Schule R, Evans RM (1991). Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. Trends Genet 7:377-381.
10. Yamamoto KR, Pearce D, Thomas J, Miner JN (1993). Combinatorial regulation at a mammalian composite element. In: McKnight S, Yamamoto KR (eds), Transcriptional Regulation, Cold Spring Harbor Press, Cold Spring Harbor, NY, pp. 3-22.
11. Saatcioglu F, Claret F-X, Karin M (1994). Negative transcriptional regulation by nuclear receptors. Semin Cancer Biol 5:347-359.
12. Imai E, Miner JN, Mitchell JA, Yamamoto KR, Granner DK (1993). Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 268:5353-5356.
13. Stein B, Yang MX (1995). Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-αB and C/EBPβ. Mol Cell Biol 15:4971-4979.
14. Stein B, Baldwin AS, Ballard DW, Greene WC, Angel P, Herrlich P (1993). Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 12: 3879-3891.
15. Ray A, Prefontame KE (1994). Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756.
16. Caldenhoven E, Liden J, Wissnik S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson J-A, Van der Saag PT (1995). Negative cross-talk between ReIA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9:401-412.
17. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr (1995). Characterization of mechanisms involved in transrepression of NF-κB activated glucocorticoid receptors. Mol Cell Biol 15:943-953.
18. Kutoh E, Stromstedt PE, Poellinger L (1992). Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1 ) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1. Mol Cell Biol 12:4960-4969.
19. Teurich S, Angel P (1995). The glucocorticoid receptor synergizes with Jun homodimers to activate AP-1-regulated promoters lacking GR binding sites. Chem Senses 20:251-255.
20. Jonat C, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H, Herrlich P (1990). Anti-tumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204.
21. König H, Ponta H, Rahmsdorf HJ, Herrlich P (1992). Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 11:2241-2246.
22. Reik A, Stewart AF, Schütz G (1994). Cross-talk modulation of signal transduction pathways: two mechanisms are involved in the control of tyrosine aminotransferase gene expression by phorbol esters. Mol Endochnol 8:490-497.
23. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR (1990). Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272.
24. Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM (1990). Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226.
25. Godowski PJ, Sakai DD, Yamamoto KR (1989). UCLA Symp Mol Cell Biol New Ser 95:197-210.
26. Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P, Cato ACB (1994). A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 13:4087-4095.
27. Kurokawa R, Söderström M, Hörlein A, Halachmi S, Brown M, Rosenfeld MG, Glass C (1995). Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454.
28. Chen JD, Evans RM (1995). A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
29. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harley E, Graupner G, Lu XP, Pfahl M (1994). A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372:107-111.
30. Alksnis M, Barkhem T, Stromstedt PE, Ahola H, Kutoh E, Gustafsson JA, Poellinger L, Nilsson S (1991). High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. Demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein. J Biol Chem 266:10078-10085.
31. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
32. Hagmeyer BM, König H, Herr I, Offringa R, Zantema A, van der Eb A, Herrlich P, Angel P (1993). Adenovirus E1A negatively and positively modulates transcription of AP-1 dependent genes by dimer-specific regulation of the DNA binding and transactivation activities of Jun. EMBO J 12:3559-3572.
33. Bartel P, Chien CT, Sternglanz R, Fields S (1993). Elimination of false positives that arise in using the two-hybrid system. Biotechniques 14:920-920.
34. Pearson WR, Lipman DJ (1988). Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85:2444-2448.
35. Wright AP, McEwan IJ, Dahlman-Wright K, Gustafsson JA (1991). High level expression of the major transactivation domain of the human glucocorticoid receptor in yeast cells inhibits endogenous gene expression and cell growth. Mol Endocrinol 5:1366-1372.
36. Seufert W, Futcher B, Jentsch S (1995). Role of a ubiquitinconjugating enzyme in degradation of S- and M-phase cyclins. Nature 373:78-81.
37. Hochstrasser M (1995). Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 7:215-230.
38. Treier M, Staszewski LM, Bohmann D (1994). Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78:787-798.
39. Hoeck W, Rusconi S, Groner B (1989). Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. Investigations with a monospecific antiserum against a bacterially expressed receptor fragment. J Biol Chem 264:14396-14402.
40. Angel P, Allegretto EA, Okino ST, Hattori K, Boyle WJ, Hunter T, Karin M (1988). Oncogene jun encodes a sequence-specific transactivator similar to AP-1. Nature 332:166-171.